Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells.

MLA

Yuanyan Wei, et al. “Activation of PI3K/Akt Pathway by CD133-P85 Interaction Promotes Tumorigenic Capacity of Glioma Stem Cells.” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 17, Apr. 2013, pp. 6829–34. EBSCOhost, https://doi.org/10.1073/pnas.1217002110.

APA

Yuanyan Wei, Yizhou Jiang, Fei Zou, Yingchao Liu, Shanshan Wang, Nuo Xu, Wenlong Xu, Chunhong Cui, Yang Xing, Ying Liu, Benjin Cao, Chanjuan Liu, Guoqiang Wu, Hong Ao, Xiaobiao Zhang, & Jianhai Jiang. (2013). Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proceedings of the National Academy of Sciences of the United States of America, 110(17), 6829–6834. https://doi.org/10.1073/pnas.1217002110

Chicago

Yuanyan Wei, Yizhou Jiang, Fei Zou, Yingchao Liu, Shanshan Wang, Nuo Xu, Wenlong Xu, et al. 2013. “Activation of PI3K/Akt Pathway by CD133-P85 Interaction Promotes Tumorigenic Capacity of Glioma Stem Cells.” Proceedings of the National Academy of Sciences of the United States of America 110 (17): 6829–34. doi:10.1073/pnas.1217002110.